Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma

NCT03207243 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

165

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: GSK3772847
DRUG: Placebo
DRUG: Fluticasone propionate/salmeterol
DRUG: Fluticasone propionate

Sponsor

GlaxoSmithKline